6Benson K,Fields K,Hiemenz J,et al. The platelet-re- fraetory bong marrow transplant patient :prophylaxis and treatment of bleeding[J]. Semin Oncin, 1993,20 (5 Suppl 6):102-109.
7Zhou B, Zhao H, Yang RC, et al. Multi-dysfunctional pathophys- iology in ITP. Crit Rev Oncol Hematol, 2005, 54:107-116.
8Wang T, Wang Z, Yang R. Thrombopoietic growth factors in the treatment of immune thrombocytopenic purpura. Crit Rev Oncol Hematol. 2011, 77 : 172-183.
9Provan D, Stasi R, Newland AC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood, 2010,115 : 168-186.
10Brighton TA, Evans S, Castaldi PA, et al. Prospective evaluation of the clinical usefulness of an antigen-specific assay (MAIPA) in idiopathic thrombocytopenic purpura and other immune thrombocy- topenias. Blood, 1996,88 : 194-201.
